Citadel Advisors - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$8,394,581
-82.4%
203,505
-76.2%
0.00%
-88.9%
Q2 2023$47,652,181
-37.8%
853,370
-37.8%
0.01%
-47.1%
Q1 2023$76,550,965
+39.6%
1,372,127
-8.8%
0.02%
+41.7%
Q4 2022$54,820,372
+329.2%
1,504,401
+235.4%
0.01%
+500.0%
Q3 2022$12,773,000
+24.5%
448,481
+97.8%
0.00%
-33.3%
Q2 2022$10,260,000
+46.0%
226,733
+145.4%
0.00%
+200.0%
Q1 2022$7,029,000
-46.9%
92,400
+4.0%
0.00%
-50.0%
Q4 2021$13,231,000
-56.4%
88,816
-57.4%
0.00%
-66.7%
Q3 2021$30,371,000
+32.3%
208,622
+78.0%
0.01%
+50.0%
Q2 2021$22,957,000
+202.5%
117,230
+179.6%
0.00%
+100.0%
Q1 2021$7,588,000
-78.9%
41,926
-83.5%
0.00%
-80.0%
Q4 2020$35,922,000
+69.3%
253,681
+49.1%
0.01%
+66.7%
Q3 2020$21,216,000
+485.9%
170,165
+319.6%
0.01%
+500.0%
Q2 2020$3,621,000
-17.8%
40,557
-42.6%
0.00%
-50.0%
Q1 2020$4,404,000
+15.9%
70,661
+41.8%
0.00%
+100.0%
Q4 2019$3,799,000
-28.5%
49,818
-52.8%
0.00%
-66.7%
Q3 2019$5,316,000105,4700.00%
Other shareholders
10X GENOMICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Venrock Management VI, LLC 8,185,565$952,538,00099.56%
Foresite Capital Management I, LLC 2,750,000$342,870,00096.54%
Foresite Capital Management II, LLC 3,503,528$436,820,00095.05%
12 West Capital Management LP 1,922,000$239,635,00011.66%
FINANCIAL CONSULATE, INC 163,366$20,368,0009.67%
JS Capital Management LLC 606,400$75,606,0003.91%
Asymmetry Capital Management, L.P. 43,512$5,425,0003.49%
Pinz Capital Management, LP 55,400$6,907,0002.52%
HAMILTON LANE ADVISORS LLC 37,087$4,624,0002.24%
RTW INVESTMENTS, LP 660,933$82,405,0001.98%
View complete list of 10X GENOMICS INC shareholders